Key Highlights

  • Health In Tech swung to a loss in the second quarter of 2026 but reaffirmed its full-year Revenue guidance of roughly $45 million to $50 million.
  • The company operates a technology platform designed to simplify Underwriting and administration for self-funded health plans.
  • The self-funded insurance market for smaller employers is large and has historically been underserved by technology, giving the company an addressable opportunity.
  • As a recently public, small company, Health In Tech's Investment case rests on scaling revenue while moving toward profitability.

Health In Tech (NASDAQ:HIT) is an insurance-technology company aiming to streamline how small and mid-sized employers access self-funded health plans. The company reported second-quarter 2026 results that showed a swing to a loss but a reaffirmed full-year revenue outlook.

Health In Tech targets a real inefficiency in the health-insurance market, but as a recently public, small company it must prove its platform can scale profitably.

A Loss but Reaffirmed Guidance

For the second quarter of 2026, Health In Tech swung to a loss but reaffirmed its full-year revenue guidance of roughly $45 million to $50 million, signaling management's continued confidence in its growth trajectory despite the quarterly loss. The company operates a technology platform designed to simplify underwriting and administration for self-funded health plans, using automation to help Brokers and smaller employers access arrangements that were traditionally complex and costly. Reaffirming guidance amid a loss suggests management views the near-term profitability pressure as consistent with its investment for growth.

Business and Financial Position

Health In Tech provides a technology-enabled platform for underwriting and administering self-funded health plans, targeting brokers and small-to-mid-sized employers with tools that automate quoting and streamline processes. Its model aims to generate recurring, technology-driven revenue as it grows its platform's adoption. As a recently public, small company, its investment case rests on scaling revenue while moving toward profitability.

Delivering on Guidance Is the Near-Term Test

The key signals are revenue growth relative to the reaffirmed guidance, progress toward profitability, and adoption of the platform among brokers and employers. Investors will be monitoring gross margins, the drivers of losses, cash runway and any financing, along with competition in insurtech and the health of the small-employer insurance market.

The market for self-funded health plans among smaller employers has historically been complex and paperwork-heavy, which is precisely the inefficiency Health In Tech's automation aims to remove. As a recently public, small company, though, it has yet to prove it can scale profitably.